In summary, the in vitro data presented, demonstrate that calcitriol modifies the phenotype of SLE MACs, restoring them towards those of healthy controls, and augments both the angiogenic capacity of MACs and the paracrine regulation of eNOS. Here, NOS3 is linked to systemic lupus erythematosus.